Wednesday, May 7, 2025

Latest

Cronos Confirms That It Has Received Expressions Of Interest, While Curaleaf Refuses To Comment

Cronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number” of unsolicited indications of interest for the potential sale of the company.

The indications of interest are said to come from third parties, with each involving a potential transaction. Cronos however has not provided details on who is seemingly interested in acquiring the company, instead electing to state that it is in the early stages of reviewing each offer, and that there can be no assurance that anything comes of the discussions.

The announcement follows a rumor that was leaked and reported on by Reuters, who suggested that the Canadian cannabis operator was in discussions to be acquired by Curaleaf Holdings (CSE: CURA), a US-based multi-state operator.

Curaleaf for its part at the request of IIROC this morning commented on the media reports, just to say that the company’s policy is “to refrain from commenting on market rumors.”

The confirmation of third party expressions of interest being received by Cronos all but confirms that the “leak” was conducted in an attempt to get a higher figure in a potential sale. That strategy however has appeared to fail spectacularly, with Cronos closing down 3%, after initially jumping over 19%.


Information for this briefing was found via Sedar, Reuters and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

Curaleaf: Consensus Estimate Falls To $20.18 After Weak Guidance

On March 3rd, Curaleaf Holdings, Inc. (CSE: CURA) reported its fourth quarter and full year...

Friday, March 11, 2022, 04:20:00 PM

Cronos Reports First Quarter Revenues of $8.4 Million, Writes Off $8.0 Million In Inventory

Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its first quarter 2020 financial results early this...

Friday, May 8, 2020, 08:34:35 AM

Curaleaf Closes European Transaction, Immediately Sells 31.5% Stake To Undisclosed Strategic Investor

Curaleaf Holdings (CSE: CURA) this morning announced the completion of EMMAC Life Sciences, a vertically...

Wednesday, April 7, 2021, 08:38:43 AM

Curaleaf Purchases Portugese Processing Assets From Clever Leaves

At a time that most cannabis operators are cutting back operations in an effort to...

Wednesday, July 5, 2023, 08:36:33 AM

Curaleaf Holdings Reports Negative Revenue Growth In Q1, Replaces CEO

Growth appears to have gone negative within the US cannabis space. Following Green Thumb Industries...

Tuesday, May 10, 2022, 08:23:47 AM